| Project/Area Number |
20K18934
|
|---|
| Research Category |
Grant-in-Aid for Early-Career Scientists
|
| Allocation Type | Multi-year Fund |
|---|
| Review Section |
Basic Section 58030:Hygiene and public health-related: excluding laboratory approach
|
|---|
| Research Institution | Hitotsubashi University |
|---|
Principal Investigator |
ROUYARD Thomas 一橋大学, 社会科学高等研究院, HIAS客員研究員 (40859542)
|
|---|
| Project Period (FY) |
2020-04-01 – 2025-03-31
|
| Project Status |
Completed (Fiscal Year 2024)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2021: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2020: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
|---|
| Keywords | Type 2 diabetes / Primary care / Cluster randomised trial / Behavioral intervention / General practice / Family medicine / Boost / RCT / Risk communication / type 2 diabetes / self-management / behavioural intervention / risk communication / heart age / primary care / cluster randomised trial / nudge / shared decision-making |
|---|
| Outline of Research at the Start |
This study will explore the effects of using an innovative risk communication tool developed to help physicians better communicate diabetes-related risks during routine consultation. The impact on patients' risk perceptions, doctor-patient communication, and risk management will be assessed.
|
| Outline of Final Research Achievements |
This research aimed to test a new, personalized approach to help people in Japan with Type 2 diabetes manage their condition more effectively. The idea was to introduce this approach during regular doctor visits and evaluate its effectiveness through a rigorous method called a "randomized controlled trial", which is widely used to accurately measure the impact of health interventions. However, we faced two main challenges. First, the COVID-19 pandemic placed additional pressure on doctors, making it difficult for them to join the study. Second, even after the pandemic eased, it remained very difficult to involve doctors in this kind of research in Japan. Common barriers include limited time, lack of incentives, and minimal training in research methods. To address these challenges, we published an article highlighting these issues and calling for changes to better support behavioral research in everyday medical practice in Japan.
|
| Academic Significance and Societal Importance of the Research Achievements |
Scientifically, this research advances the use of behavioral interventions for chronic disease in routine care to improve patients' lives. Socially, it exposes key barriers to such research in Japan and calls for reforms to enable patient-centered innovation in everyday healthcare.
|
